Autopsy report · NCT02237547

Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury

“No enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Translational Biosciences

Sponsor type

Industry

Conditions

Spinal Cord Injury

Interventions

Intravenous and intrathecal human umbilical cord tissue-derived mesenchymal stem cells and bone marrow mononuclear cells

Participants

0

Sites

1

Countries

Panama

Trials that died the same way

• Intraosseous Basivertebral Nerve Ablation for Treatment of Chronic Low Back Pain
  “No Enrollments” (93% match in meaning)
• The "Peripheral Access Utilizing Sonographic Evaluation" Study
  “No enrollment was achieved” (83% match in meaning)
• Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity
  “Enrollment too low.” (79% match in meaning)
• The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
  “Low enrollment.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.